Follow
A.G. van der Heijden
A.G. van der Heijden
Unknown affiliation
Verified email at radboudumc.nl
Title
Cited by
Cited by
Year
Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer
JA Witjes, T Lebret, EM Compérat, NC Cowan, M De Santis, HM Bruins, ...
European urology 71 (3), 462-475, 2017
1516*2017
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines
JA Witjes, E Compérat, NC Cowan, M De Santis, G Gakis, T Lebret, ...
European urology 65 (4), 778-792, 2014
10852014
European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines
JA Witjes, HM Bruins, R Cathomas, EM Compérat, NC Cowan, G Gakis, ...
European urology 79 (1), 82-104, 2021
6792021
Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder
AG Van der Heijden, LA Kiemeney, ON Gofrit, O Nativ, A Sidi, Z Leib, ...
European urology 46 (1), 65-72, 2004
2102004
Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guérin for adjuvant treatment of patients with …
TJH Arends, O Nativ, M Maffezzini, O De Cobelli, G Canepa, F Verweij, ...
European urology 69 (6), 1046-1052, 2016
1922016
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review
HM Bruins, E Veskimae, V Hernandez, M Imamura, MM Neuberger, ...
European urology 66 (6), 1065-1077, 2014
1802014
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer
ON Gofrit, A Shapiro, D Pode, A Sidi, O Nativ, Z Leib, JA Witjes, ...
Urology 63 (3), 466-471, 2004
1462004
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study
AG van der HEIJDEN, G Verhaegh, CFJ Jansen, JA Schalken, JA Witjes
The Journal of urology 173 (4), 1375-1380, 2005
1232005
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1032020
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response
AG van der Heijden, PMJ Moonen, EB Cornel, H Vergunst, TM de Reijke, ...
The Journal of urology 176 (4), 1349-1353, 2006
932006
Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
SH Vermeulen, N Hanum, AJ Grotenhuis, G Castano-Vinyals, ...
British journal of cancer 112 (3), 594-600, 2015
892015
Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study
JA Witjes, PMJ Moonen, AG van der Heijden
European urology 47 (3), 319-322, 2005
862005
Intravesical gemcitabine: a phase 1 and pharmacokinetic study
JA Witjes, AG Van Der Heijden, JLJ Vriesema, GJ Peters, A Laan, ...
European urology 45 (2), 182-186, 2004
832004
European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification …
RJ Sylvester, O Rodríguez, V Hernández, D Turturica, L Bauerová, ...
European urology 79 (4), 480-488, 2021
782021
Recurrence, progression, and follow-up in non–muscle-invasive bladder cancer
AG van der Heijden, JA Witjes
European Urology Supplements 8 (7), 556-562, 2009
772009
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer
TJH Arends, AG van der Heijden, JA Witjes
The Journal of urology 192 (3), 708-713, 2014
752014
A five-gene expression signature to predict progression in T1G3 bladder cancer
AG van der Heijden, L Mengual, JJ Lozano, M Ingelmo-Torres, MJ Ribal, ...
European journal of cancer 64, 127-136, 2016
662016
The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines
AG van der Heijden, CFJ Jansen, G Verhaegh, MA O’Donnell, ...
European urology 46 (5), 670-674, 2004
662004
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU …
A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
Annals of Oncology 30 (11), 1697-1727, 2019
622019
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer
JH van Puffelen, ST Keating, E Oosterwijk, AG van der Heijden, MG Netea, ...
Nature Reviews Urology 17 (9), 513-525, 2020
612020
The system can't perform the operation now. Try again later.
Articles 1–20